{"record_type":"pith_number_record","schema_url":"https://pith.science/schemas/pith-number/v1.json","pith_number":"pith:2019:EAZJ6FWV3D3FPYNY43JJBRWPLX","short_pith_number":"pith:EAZJ6FWV","schema_version":"1.0","canonical_sha256":"20329f16d5d8f657e1b8e6d290c6cf5dd46db9cf80b95578e56e4853b76e4f94","source":{"kind":"arxiv","id":"1908.07751","version":1},"attestation_state":"computed","paper":{"title":"Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Beat Neuenschwander, Nicolas Scheuer, Satrajit Roychoudhury","submitted_at":"2019-08-21T08:44:52Z","abstract_excerpt":"Background: Well-designed phase II trials must have acceptable error rates relative to a pre-specified success criterion, usually a statistically significant p-value. Such standard designs may not always suffice from a clinical perspective because clinical relevance may call for more. For example, proof-of-concept in phase II often requires not only statistical significance but also a sufficiently large effect estimate.\n  Purpose: We propose dual-criterion designs to complement statistical significance with clinical relevance, discuss their methodology, and illustrate their implementation in p"},"verification_status":{"content_addressed":true,"pith_receipt":true,"author_attested":false,"weak_author_claims":0,"strong_author_claims":0,"externally_anchored":false,"storage_verified":false,"citation_signatures":0,"replication_records":0,"graph_snapshot":true,"references_resolved":false,"formal_links_present":false},"canonical_record":{"source":{"id":"1908.07751","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.AP","submitted_at":"2019-08-21T08:44:52Z","cross_cats_sorted":[],"title_canon_sha256":"bae801103d8b7ce102925f57604317443f8fd2f1dfd8efc28b61f8923387f0cb","abstract_canon_sha256":"b6e69818eb3a0bfa7566eeb16944e420b0f074bf80f6cd836e5c9e0d10c5236a"},"schema_version":"1.0"},"receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T00:38:54.655744Z","signature_b64":"zuaNgZiTJjbGjhT0ktU4qRvAAqX90I1PgYR989LM3w8KXqhVfsPClwu0ZSq2uLAPy987YMLSYth7xA6khqUHDg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"20329f16d5d8f657e1b8e6d290c6cf5dd46db9cf80b95578e56e4853b76e4f94","last_reissued_at":"2026-07-05T00:38:54.655376Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T00:38:54.655376Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"graph_snapshot":{"paper":{"title":"Beyond p-values: a phase II dual-criterion design with statistical significance and clinical relevance","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.AP","authors_text":"Beat Neuenschwander, Nicolas Scheuer, Satrajit Roychoudhury","submitted_at":"2019-08-21T08:44:52Z","abstract_excerpt":"Background: Well-designed phase II trials must have acceptable error rates relative to a pre-specified success criterion, usually a statistically significant p-value. Such standard designs may not always suffice from a clinical perspective because clinical relevance may call for more. For example, proof-of-concept in phase II often requires not only statistical significance but also a sufficiently large effect estimate.\n  Purpose: We propose dual-criterion designs to complement statistical significance with clinical relevance, discuss their methodology, and illustrate their implementation in p"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1908.07751","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/1908.07751/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"aliases":[{"alias_kind":"arxiv","alias_value":"1908.07751","created_at":"2026-07-05T00:38:54.655440+00:00"},{"alias_kind":"arxiv_version","alias_value":"1908.07751v1","created_at":"2026-07-05T00:38:54.655440+00:00"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1908.07751","created_at":"2026-07-05T00:38:54.655440+00:00"},{"alias_kind":"pith_short_12","alias_value":"EAZJ6FWV3D3F","created_at":"2026-07-05T00:38:54.655440+00:00"},{"alias_kind":"pith_short_16","alias_value":"EAZJ6FWV3D3FPYNY","created_at":"2026-07-05T00:38:54.655440+00:00"},{"alias_kind":"pith_short_8","alias_value":"EAZJ6FWV","created_at":"2026-07-05T00:38:54.655440+00:00"}],"events":[],"event_summary":{},"paper_claims":[],"inbound_citations":{"count":0,"internal_anchor_count":0,"sample":[]},"formal_canon":{"evidence_count":0,"sample":[],"anchors":[]},"links":{"html":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX","json":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX.json","graph_json":"https://pith.science/api/pith-number/EAZJ6FWV3D3FPYNY43JJBRWPLX/graph.json","events_json":"https://pith.science/api/pith-number/EAZJ6FWV3D3FPYNY43JJBRWPLX/events.json","paper":"https://pith.science/paper/EAZJ6FWV"},"agent_actions":{"view_html":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX","download_json":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX.json","view_paper":"https://pith.science/paper/EAZJ6FWV","resolve_alias":"https://pith.science/api/pith-number/resolve?arxiv=1908.07751&json=true","fetch_graph":"https://pith.science/api/pith-number/EAZJ6FWV3D3FPYNY43JJBRWPLX/graph.json","fetch_events":"https://pith.science/api/pith-number/EAZJ6FWV3D3FPYNY43JJBRWPLX/events.json","actions":{"anchor_timestamp":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX/action/timestamp_anchor","attest_storage":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX/action/storage_attestation","attest_author":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX/action/author_attestation","sign_citation":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX/action/citation_signature","submit_replication":"https://pith.science/pith/EAZJ6FWV3D3FPYNY43JJBRWPLX/action/replication_record"}},"created_at":"2026-07-05T00:38:54.655440+00:00","updated_at":"2026-07-05T00:38:54.655440+00:00"}